1Maron B J, Towbin JA, Thiene G, et classification of the cardiomyopathies al. Contemporary definitions and : An American heart association scientific statement from the council on clinical cardiology,heart failure and transplantation committee ; Quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups;and council on epidemiology and prevention [ J ]. Circulation,2006,113 (14) :1807 - 1816.
2Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis [ J ]. Circulation ,2006,114( 15 ) :1581 - 1590.
3Kuhl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction [ J]. Circulation,2005,112 ( 13 ) : 1965 - 1970.
4Cooper LT,Baughman KL,Feldman AM,et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Assodiation of the European Society of Cardiology [ J]. Circulation, 2007 , 116 ( 19 ) : 2216 - 2233.
5Caforio AL, Calabrese F, Angelini A, et al. A prospective study of bio psy - proven myocarditis: Prognostic relevance of clinical and aetiopathogenetic features at diagnosis [ J ]. Eur Heart J, 2007,28 ( 11 ) : 1326 - 1333.
6Sheppard R, Bedi M, Kubota T,et al. Myocardial expression of fas and recovery of left ventricular function in patients with recent - onset cardiomyopathy [ J ]. J Am Coll Cardiol , 2005,46 ( 6 ) : 1043 - 1044.
7Magnani JW, Dec GW. Myocarditis: Current Trends in diagnosis and treatment [ J]. Circulation,2006, 113 ( 6 ) :876 - 890.
9Friedrich MG, Sechtem U, Schulz- Menger J, et al. Cardiovascular magnetic resonance in myocarditis:A JACC white paper[J]. J Am Coil Cardiol,2009,53 ( 17 ) : 1475 - 1487.
